Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Cystic Fibrosis: Management

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...

Barrett Esophagus-II: Clinical Manifestations and Management

Barrett Esophagus-II: Clinical Manifestations and Management

Individuals with Barrett's esophagus are often asymptomatic, but they may experience symptoms commonly associated with GERD, such as heartburn and acid regurgitation. Additional symptoms can include difficulty swallowing, chest pain, unintentional weight loss, blood in the stool (which may appear black, tarry, or bloody), and episodes of vomiting.
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...

Chronic Pancreatitis II: Collaborative Care

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Setmelanotide for the Treatment of Acquired Hypothalamic Obesity.

The New England journal of medicine·2026

Same author

Case Report: First description of an intracranial "NET" in ROHHAD syndrome; time to rename to the ROHHAD-NeCT syndrome?

Frontiers in endocrinology·2026

Same author

Temporal Trends of Subsequent Malignant Neoplasms in Childhood Cancer Survivors and the Impact of Treatment Changes: A DCCSS-LATER Study.

Journal of the National Cancer Institute·2026

Same author

Management of adverse events in patients with pediatric low-grade glioma treated with MAPK-directed therapies: Delphi consensus recommendations and unmet needs.

Neuro-oncology practice·2026

Same author

Defining Acquired Hypothalamic Obesity: An Expert Call for Unified Diagnosis and Therapeutic Action.

Diabetes, obesity & metabolism·2026

Same author

Health-related quality of life in children with multiple endocrine neoplasia (MEN) and their siblings.

The Journal of clinical endocrinology and metabolism·2026

Search research articles

Related Experiment Video

Updated: Mar 8, 2026

Spontaneous Murine Model of Anaplastic Thyroid Cancer

Spontaneous Murine Model of Anaplastic Thyroid Cancer

Published on: February 3, 2023

Pediatric papillary thyroid cancer: current management challenges.

Frederik A Verburg¹, Hanneke M Van Santen², Markus Luster¹

¹University Hospital Gießen and Marburg, Department of Nuclear Medicine, Marburg, Germany.

Oncotargets and Therapy

|January 19, 2017

Summary

Pediatric differentiated thyroid cancer (DTC) is rare but increasing. This review covers diagnosis, surgery, and therapies for pediatric papillary thyroid cancer (PTC), highlighting management controversies and challenges.

Keywords:

I-131 therapy follow-up papillary thyroid cancer pediatric cancer survival treatment

More Related Videos

Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer

Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer

Published on: June 9, 2023

Establishment and Characterization of Patient-Derived Xenograft Models of Anaplastic Thyroid Carcinoma and Head and Neck Squamous Cell Carcinoma

Establishment and Characterization of Patient-Derived Xenograft Models of Anaplastic Thyroid Carcinoma and Head and Neck Squamous Cell Carcinoma

Published on: June 2, 2023

Related Experiment Videos

Last Updated: Mar 8, 2026

Spontaneous Murine Model of Anaplastic Thyroid Cancer

Spontaneous Murine Model of Anaplastic Thyroid Cancer

Published on: February 3, 2023

Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer

Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer

Published on: June 9, 2023

Establishment and Characterization of Patient-Derived Xenograft Models of Anaplastic Thyroid Carcinoma and Head and Neck Squamous Cell Carcinoma

Establishment and Characterization of Patient-Derived Xenograft Models of Anaplastic Thyroid Carcinoma and Head and Neck Squamous Cell Carcinoma

Published on: June 2, 2023

Area of Science:

Pediatric Oncology
Endocrinology

Background:

Differentiated thyroid cancer (DTC) is rare in children and adolescents, accounting for ~1.4% of pediatric malignancies, but its incidence is rising.
Limited evidence exists for optimal treatment due to rarity and long patient survival, leading to numerous controversies in pediatric DTC management.

Approach:

This review provides an overview of challenging areas in patient and disease management for pediatric papillary thyroid cancer (PTC).
It discusses current data on diagnosis, surgical approaches, radionuclide therapy, and endocrine management.

Key Points:

Key areas of controversy in pediatric PTC include diagnostic strategies, surgical extent, and the roles of radioactive iodine and long-term hormone suppression.
Addressing these controversies is crucial for optimizing outcomes in this rare pediatric malignancy.

Conclusions:

Optimal management strategies for pediatric PTC remain debated, necessitating further research and evidence-based guidelines.
This review highlights critical areas requiring attention to improve the care and long-term outcomes for children and adolescents with PTC.